AQP5 and liver dysplastic nodule: AQP5 is obviously increased in the kidney tissue of DN patients and urine AQP2 and AQP5 have been identified as potential novel biomarkers of diabetic nephropathy with sensitivity, early appearance, and low invasiveness features [68,69,70].